HANK & LIN'S GROUP
The past is prologue and the future is scintillating
五羟色胺转运体SERT（5HTT）显像剂
[18F]-FPBM2 & FPBM : SERT(5HTT) imaging agents Publications:
1.Liu, F, et al. "Deuterium‐substituted 2‐(2′‐((dimethylamino) methyl)‐4′‐[18F](fluoropropoxy) phenylthio) benzenamine as a serotonin transporter imaging agent." Journal of Labelled Compounds and Radiopharmaceuticals 61.8 (2018): 576-585.
2.Zhang, Y., et al. "Fluorine-18 labeled diphenyl sulfide derivatives for imaging serotonin transporter (SERT) in the brain." Nuclear medicine and biology 66 (2018): 1-9.
3.Sun, M., et al. "Rapid screening of nine unradiolabeled candidate compounds as PET brain imaging agents using cassette-wave microdosing and LC-MS/MS." Journal of Chromatography B 1121 (2019): 28-38.
4.Zhu, L., et al. "An improved preparation of [18F] FPBM: a potential serotonin transporter (SERT) imaging agent." Nuclear medicine and biology 40.8 (2013): 974-979.
5.Qiao, H., et al. "One-step preparation of [18F] FPBM for PET imaging of serotonin transporter (SERT) in the brain." Nuclear medicine and biology 43.8 (2016): 470-477.
6.Xiao, H., et al. "Developing a cassette microdosing approach to enhance the throughput of PET imaging agent screening." Journal of pharmaceutical and biomedical analysis 154 (2018): 48-56.
7.Wang, JL., et al. "In vivo studies of the SERT-selective [18F] FPBM and VMAT2-selective [18F] AV-133 radiotracers in a rat model of Parkinson's disease." Nuclear medicine and biology 37.4 (2010): 479-486.
